Klaus Berding has more than 25 years’ work experience in banking and consulting, mainly focusing on the Life Sciences and Technology sectors.
In 2003, he started his own corporate finance and consulting business LSFA-Life Science & Financing, and he has been part of BRESLIN’s operating team since 2005. He is a co-founder of Amypopharma in Italy, a spin-off from UNIMIB, and he serves as a member of its board. For more than 10 years, Klaus has been active as a coach and expert reviewer for European VC events, organized by TechTour.
He before worked at Dresdner Kleinwort, starting in Equity Research and thereafter moving to Corporate Finance. As SVP and Director in the Industry Group Chemicals & Healthcare, he was responsible for managing member relations and had an active role in building the international equity business of the Bank. During this tenure, he was instrumental in setting up a joint collaboration with an Israeli Investment bank to develop its IPO business and corporate finance activities. He participated in or led over 40 IPOs and capital market transactions and was involved in spin-offs and M&A mandates.
Klaus holds an MBA from Ruhr University Bochum and has a post-graduate degree from the DVFA (Association of German Investment Professionals).
He participated in the 1st European seminar on “Business Development Basics Life Sciences”, jointly organized by BIO Organization, E.B.D. Group (Event Organizer), and LES (Licensing Executives Society) in Frankfurt (2003), as well as in the Private Equity & Venture Capital Management Training in Barcelona in 2004, organized by EVCA. He is also a member of the House of Pharma, an association actively supporting the development of the Life Sciences’ sector in Germany’s Rhein-Main area.
1.2
DETAILS & STRUCTURE OF BRESLIN’S ENGAGEMENT
The whole scope of services of BRESLIN could be divided into five phases of engagement (A to E):
A. PREPARATION (approx. 2 weeks)
a) Verifying base of collaboration between MYMETICS and the potential partner (collection & review of existing information); b) Preparing information package in cooperation with MYMETICS.
B. SEARCH & IDENTIFICATION (approx. 2-3 weeks)
a) Screening of BRESLIN’s global network and international deal flow to identify potential and qualified partners for a strategic partnership, exit or equity financing; b) Prioritizing potential partners based on previously defined criteria; c) Deliverable: short list of at least 8 to 10 mutually agreed potential partners with prioritization to be approached in phase C.
C. APPROACH & CONTACTING (8 - 10 weeks)
a) Personal approach of selected potential partners by BRESLIN; b) Providing interested potential partners with non-confidential information packages; c) Submitting CDAs prior to disclosure of any confidential material to interested potential partners; d) Organizing conference calls and preliminary negotiations with interested potential partners of possible terms and conditions, in particular financial terms; e) Reporting to MYMETICS every two weeks by telephone conferences or by way of written activity spreadsheets; f) Milestone: go / no-go decision of MYMETICS based on interest and likelihood of closing deal with interested potential partners.
D. NEGOTIATION & DUE DILIGENCE (6 - 8 weeks)
a) Organizing conference calls and detailed discussions with selected potential partners of terms and conditions, in particular financial terms; support and establishment of due diligence dataroom(s); b) Negotiating with selected potential Partners together with the management of MYMETICS; c) Support and assistance of pre-Transaction due diligence with various types of risk estimations and modifications of proposed models; d) Signing of formal “Letter of Intent” (LOI); e) Support and assistance with final due diligence of data, materials, agreements and selected potential partners; coordination of legal activities; coordination of individual participants and parties to the intranasal flu vaccination program, etc.
E. FINALIZATION & CLOSING (approx. 4 weeks)
a) Support and assistance in final negotiations with selected potential partners; b) Last minute modifications of services upon MYMETICS’ request; c) Coordination and support of all parties in closing procedures.
News 
Market Data 
Discover 
